Manju Sengar

4.6k total citations
169 papers, 1.3k citations indexed

About

Manju Sengar is a scholar working on Oncology, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, Manju Sengar has authored 169 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Oncology, 48 papers in Pathology and Forensic Medicine and 46 papers in Hematology. Recurrent topics in Manju Sengar's work include Lymphoma Diagnosis and Treatment (46 papers), Chronic Lymphocytic Leukemia Research (29 papers) and Economic and Financial Impacts of Cancer (28 papers). Manju Sengar is often cited by papers focused on Lymphoma Diagnosis and Treatment (46 papers), Chronic Lymphocytic Leukemia Research (29 papers) and Economic and Financial Impacts of Cancer (28 papers). Manju Sengar collaborates with scholars based in India, United States and Canada. Manju Sengar's co-authors include Richard Sullivan, Hari Menon, Christopher M. Booth, Reena Nair, Sumeet Gujral, Wilma M. Hopman, Adam Fundytus, Hasmukh Jain, Bhausaheb Bagal and Nazik Hammad and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Manju Sengar

146 papers receiving 1.3k citations

Peers

Manju Sengar
Jonas Paludo United States
Sidney Scudder United States
Scott F. Huntington United States
Norbert Marschner Germany
Ray D. Page United States
Carol M. Richman United States
Jane Bryce Italy
Silvia Dehler Switzerland
Gladys Rodriguez United States
Iuliana Shapira United States
Jonas Paludo United States
Manju Sengar
Citations per year, relative to Manju Sengar Manju Sengar (= 1×) peers Jonas Paludo

Countries citing papers authored by Manju Sengar

Since Specialization
Citations

This map shows the geographic impact of Manju Sengar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manju Sengar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manju Sengar more than expected).

Fields of papers citing papers by Manju Sengar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manju Sengar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manju Sengar. The network helps show where Manju Sengar may publish in the future.

Co-authorship network of co-authors of Manju Sengar

This figure shows the co-authorship network connecting the top 25 collaborators of Manju Sengar. A scholar is included among the top collaborators of Manju Sengar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manju Sengar. Manju Sengar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pramesh, C.S., Manju Sengar, Priya Ranganathan, et al.. (2025). Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India. BMJ evidence-based medicine. 30(Suppl 2). s20–s28. 1 indexed citations
2.
Jain, Bhav, Puneeth Iyengar, James Fan Wu, et al.. (2025). Hematologic cancers in the SAARC region: current burden in 2022 and projections to 2050. 2(1). 100036–100036.
3.
Wilson, Brooke E., Manju Sengar, Michelle Tregear, et al.. (2024). Common Sense Oncology: Equity, Value, and Outcomes That Matter. American Society of Clinical Oncology Educational Book. 44(3). e100039–e100039. 4 indexed citations
4.
Desai, P. B., Bhausaheb Bagal, Chetan Dhamne, et al.. (2023). Navigating the neutropenic abyss with granulocyte transfusions: Retrospective single‐center analysis of effectiveness and safety in India. Journal of Clinical Apheresis. 38(6). 703–710. 3 indexed citations
5.
6.
Nair, Reena, Narendra Agrawal, Manju Sengar, et al.. (2023). Real-world outcomes of diffuse large B-cell lymphoma in the biosimilar era. Frontiers in Oncology. 13. 1248723–1248723.
7.
Sengar, Manju, Hasmukh Jain, Murari Gurjar, et al.. (2023). A Prospective Study to Evaluate the Effect of Therapeutic Drug Monitoring-Based Posaconazole Prophylaxis on Invasive Fungal Infection Rate During Acute Myeloid Leukemia Induction Therapy. Indian Journal of Hematology and Blood Transfusion. 40(2). 204–212. 4 indexed citations
8.
Sengar, Manju, et al.. (2023). Design of a clinical trial using generalized pairwise comparisons to test a less intensive treatment regimen. Clinical Trials. 21(2). 180–188. 7 indexed citations
9.
Denburg, Avram, Adam Fundytus, Muhammad Saghir Khan, et al.. (2022). Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey. JCO Global Oncology. 8(8). e2200034–e2200034. 8 indexed citations
10.
Barrios, Carlos H., Gilberto Lopes, Mastura Md Yusof, et al.. (2022). Barriers in access to oncology drugs — a global crisis. Nature Reviews Clinical Oncology. 20(1). 7–15. 60 indexed citations
11.
Sengar, Manju, Hasmukh Jain, Tanuja Shet, et al.. (2022). Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)‐associated lymphomas. British Journal of Haematology. 200(4). 429–439. 1 indexed citations
12.
Trapani, Dario, Kiu Tay-Teo, Felipe Roitberg, et al.. (2022). Implications of Oncology Trial Design and Uncertainties in Efficacy-Safety Data on Health Technology Assessments. Current Oncology. 29(8). 5774–5791. 11 indexed citations
13.
Sengar, Manju, Adam Fundytus, Wilma M. Hopman, et al.. (2022). Cancer Medicines: What Is Essential and Affordable in India?. JCO Global Oncology. 8(8). e2200060–e2200060. 11 indexed citations
14.
Jain, Hasmukh, Manju Sengar, Prashant Tembhare, et al.. (2021). Bortezomib and rituximab in de novo adolescent/adult CD20-positive, Ph-negative pre-B-cell acute lymphoblastic leukemia. Blood Advances. 5(17). 3436–3444. 10 indexed citations
15.
Jain, Hasmukh, Lingaraj Nayak, Prashant Tembhare, et al.. (2021). Outcomes and prognostic factors in adolescents and young adults with ALL treated with a modified BFM-90 protocol. Blood Advances. 5(5). 1178–1193. 22 indexed citations
16.
Jalink, Matthew, Fábio Ynoe de Moraes, Christopher M. Booth, et al.. (2021). Tracking the Workforce 2020-2030: Making the Case for a Cancer Workforce Registry. JCO Global Oncology. 7(7). 925–933. 10 indexed citations
17.
Kumar, Sushant, Sarbari Ghosh, Alka Dwivedi, et al.. (2020). The Th9 Axis Reduces the Oxidative Stress and Promotes the Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma Patients. Molecular Cancer Research. 18(4). 657–668. 23 indexed citations
18.
19.
Nayak, Lingaraj, Hasmukh Jain, Avinash Bonda, et al.. (2020). Hodgkin Lymphoma in Adolescent and Young Adults: Real-World Data from a Single Tertiary Cancer Center in India. Journal of Adolescent and Young Adult Oncology. 10(5). 581–587. 2 indexed citations
20.
Prasad, Maya, Gaurav Narula, Girish Chinnaswamy, et al.. (2018). Unfavorable presentation but comparable outcome: Presentation and outcome of children with nodular lymphocyte predominant Hodgkin lymphoma from India. Pediatric Blood & Cancer. 65(10). e27288–e27288. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jonas Paludo Breakdown of academic impact, for papers by Sidney Scudder Breakdown of academic impact, for papers by Scott F. Huntington Breakdown of academic impact, for papers by Norbert Marschner Breakdown of academic impact, for papers by Ray D. Page Breakdown of academic impact, for papers by Carol M. Richman Breakdown of academic impact, for papers by Jane Bryce Breakdown of academic impact, for papers by Silvia Dehler Breakdown of academic impact, for papers by Gladys Rodriguez Breakdown of academic impact, for papers by Iuliana Shapira
Rankless by CCL
2026